 5. There is any finding in the participants medical history, physical examination, or safety laboratory tests including safety electroencephalogram EEG giving reasonable suspicion of a disease that would contraindicate taking TAK-137, or a similar drug in the same class, or that might interfere with the conduct of the study. This includes, but is not limited to, peptic ulcer disease, seizure disorders, and cardiac arrhythmias. 